2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride

C97H114B2BrCl3N24O11 — CID 159307963

IUPAC2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride
SMILESCC(C)(C)OC(=O)N1CCc2cc(B3OC(C)(C)C(C)(C)O3)ccc2C1.CC(C)(C)c1noc(C(=O)O)n1.Cl.Clc1ccnc2nc(Br)[nH]c12.Cn1cc(-c2nc3nccc(-c4ccc5c(c4)CCCC5)c3[nH]2)cn1.Cn1cc(-c2nc3nccc(-c4ccc5c(c4)CCN(C(=O)OC(C)(C)C)C5)c3[nH]2)cn1.Cn1cc(-c2nc3nccc(Cl)c3[nH]2)cn1.Cn1cc(B2OC(C)(C)C(C)(C)O2)cn1
InChIInChI=1S/C24H26N6O2.C20H30BNO4.C20H19N5.C10H17BN2O2.C10H8ClN5.C7H10N2O3.C6H3BrClN3.ClH/c1-24(2,3)32-23(31)30-10-8-15-11-16(5-6-17(15)14-30)19-7-9-25-22-20(19)27-21(28-22)18-12-26-29(4)13-18;1-18(2,3)24-17(23)22-11-10-14-12-16(9-8-15(14)13-22)21-25-19(4,5)20(6,7)26-21;1-25-12-16(11-22-25)19-23-18-17(8-9-21-20(18)24-19)15-7-6-13-4-2-3-5-14(13)10-15;1-9(2)10(3,4)15-11(14-9)8-6-12-13(5)7-8;1-16-5-6(4-13-16)9-14-8-7(11)2-3-12-10(8)15-9;1-7(2,3)6-8-4(5(10)11)12-9-6;7-6-10-4-3(8)1-2-9-5(4)11-6;/h5-7,9,11-13H,8,10,14H2,1-4H3,(H,25,27,28);8-9,12H,10-11,13H2,1-7H3;6-12H,2-5H2,1H3,(H,21,23,24);6-7H,1-5H3;2-5H,1H3,(H,12,14,15);1-3H3,(H,10,11);1-2H,(H,9,10,11);1H
InChIKeyVLQCOEYCNZUUAF-UHFFFAOYSA-N
MW2000.02 g/mol
LogP18.09
Rot. Bonds8

About 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride

2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride (PubChem CID 159307963) has the molecular formula C97H114B2BrCl3N24O11 and a molecular weight of 2000.02 g/mol. Its IUPAC name is 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride.

Molecular Properties

Compound Name2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride
PubChem CID159307963
Molecular FormulaC97H114B2BrCl3N24O11
Molecular Weight2000.02 g/mol
Exact Mass1996.75
IUPAC Name2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride
SMILESCC(C)(C)OC(=O)N1CCc2cc(B3OC(C)(C)C(C)(C)O3)ccc2C1.CC(C)(C)c1noc(C(=O)O)n1.Cl.Clc1ccnc2nc(Br)[nH]c12.Cn1cc(-c2nc3nccc(-c4ccc5c(c4)CCCC5)c3[nH]2)cn1.Cn1cc(-c2nc3nccc(-c4ccc5c(c4)CCN(C(=O)OC(C)(C)C)C5)c3[nH]2)cn1.Cn1cc(-c2nc3nccc(Cl)c3[nH]2)cn1.Cn1cc(B2OC(C)(C)C(C)(C)O2)cn1
InChIInChI=1S/C24H26N6O2.C20H30BNO4.C20H19N5.C10H17BN2O2.C10H8ClN5.C7H10N2O3.C6H3BrClN3.ClH/c1-24(2,3)32-23(31)30-10-8-15-11-16(5-6-17(15)14-30)19-7-9-25-22-20(19)27-21(28-22)18-12-26-29(4)13-18;1-18(2,3)24-17(23)22-11-10-14-12-16(9-8-15(14)13-22)21-25-19(4,5)20(6,7)26-21;1-25-12-16(11-22-25)19-23-18-17(8-9-21-20(18)24-19)15-7-6-13-4-2-3-5-14(13)10-15;1-9(2)10(3,4)15-11(14-9)8-6-12-13(5)7-8;1-16-5-6(4-13-16)9-14-8-7(11)2-3-12-10(8)15-9;1-7(2,3)6-8-4(5(10)11)12-9-6;7-6-10-4-3(8)1-2-9-5(4)11-6;/h5-7,9,11-13H,8,10,14H2,1-4H3,(H,25,27,28);8-9,12H,10-11,13H2,1-7H3;6-12H,2-5H2,1H3,(H,21,23,24);6-7H,1-5H3;2-5H,1H3,(H,12,14,15);1-3H3,(H,10,11);1-2H,(H,9,10,11);1H
InChIKeyVLQCOEYCNZUUAF-UHFFFAOYSA-N
XLogP18.09
TPSA409.78 Ų
H-Bond Donors5
H-Bond Acceptors28
Rotatable Bonds8
Heavy Atoms138
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002000.02
LogP ≤ 518.09
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride?
The IUPAC name of 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride (CID 159307963) is 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride.
What is the SMILES notation for 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride?
The canonical SMILES for 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride is CC(C)(C)OC(=O)N1CCc2cc(B3OC(C)(C)C(C)(C)O3)ccc2C1.CC(C)(C)c1noc(C(=O)O)n1.Cl.Clc1ccnc2nc(Br)[nH]c12.Cn1cc(-c2nc3nccc(-c4ccc5c(c4)CCCC5)c3[nH]2)cn1.Cn1cc(-c2nc3nccc(-c4ccc5c(c4)CCN(C(=O)OC(C)(C)C)C5)c3[nH]2)cn1.Cn1cc(-c2nc3nccc(Cl)c3[nH]2)cn1.Cn1cc(B2OC(C)(C)C(C)(C)O2)cn1.
What is the InChIKey of 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride?
The InChIKey is VLQCOEYCNZUUAF-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26N6O2.C20H30BNO4.C20H19N5.C10H17BN2O2.C10H8ClN5.C7H10N2O3.C6H3BrClN3.ClH/c1-24(2,3)32-23(31)30-10-8-15-11-16(5-6-17(15)14-30)19-7-9-25-22-20(19)27-21(28-22)18-12-26-29(4)13-18;1-18(2,3)24-17(23)22-11-10-14-12-16(9-8-15(14)13-22)21-25-19(4,5)20(6,7)26-21;1-25-12-16(11-22-25)19-23-18-17(8-9-21-20(18)24-19)15-7-6-13-4-2-3-5-14(13)10-15;1-9(2)10(3,4)15-11(14-9)8-6-12-13(5)7-8;1-16-5-6(4-13-16)9-14-8-7(11)2-3-12-10(8)15-9;1-7(2,3)6-8-4(5(10)11)12-9-6;7-6-10-4-3(8)1-2-9-5(4)11-6;/h5-7,9,11-13H,8,10,14H2,1-4H3,(H,25,27,28);8-9,12H,10-11,13H2,1-7H3;6-12H,2-5H2,1H3,(H,21,23,24);6-7H,1-5H3;2-5H,1H3,(H,12,14,15);1-3H3,(H,10,11);1-2H,(H,9,10,11);1H.
What are the key properties of 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride?
2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride has a molecular weight of 2000.02 g/mol, XLogP of 18.09, 8 rotatable bonds, 5 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-7-chloro-1H-imidazo[4,5-b]pyridine;tert-butyl 6-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;3-tert-butyl-1,2,4-oxadiazole-5-carboxylic acid;tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;7-chloro-2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine;2-(1-methylpyrazol-4-yl)-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-imidazo[4,5-b]pyridine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;hydrochloride is sourced from PubChem (CID 159307963), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).